Reduction of Platelet Hyperactivity by Polyphenol in An Experimental Model of Alzheimer's Disease in Rats
The American Journal of Agriculture and Biomedical Engineering · 01.03.2026 · 8 (3) · 10-16
DOI: 10.37547/tajabe/volume08issue03-03 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Agriculture and Biomedical Engineering, online erschienen am 01.03.2026. Verfasst von Yuldasheva G.K. und 8 weiteren Autor:innen.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer's disease (AD) is increasingly associated not only with neuronal degeneration but also with platelet dysfunction, altered hemostasis, and calcium-dependent peripheral signaling abnormalities.
Objective
To evaluate the effects of G-40 polyphenol on platelet aggregation, coagulation hemostasis, and intracellular calcium mobilization in a rat AD-like condition.
Methods
Platelet-rich plasma and platelet suspensions obtained from control rats and rats with an AlCl3-induced AD-like condition were analyzed. Platelet aggregation was assessed by Born aggregometry after stimulation with ADP, adrenaline, and collagen. Coagulation was evaluated using thrombin time (TT), activated partial thromboplastin time (APTT/QFTV), and prothrombin time (PT, TechPlastin). Intracellular calcium was monitored in Fluo-4 AM-loaded platelets after ADP stimulation, with EGTA used as a calcium-chelating control. G-40 was tested primarily at 50 uM, with concentration-response evaluation in the 10-100 uM range for calcium readouts.
Results
The AD model displayed spontaneous platelet aggregation and enhanced agonist-induced aggregation relative to controls. G-40 partially inhibited ADP- and collagen-induced aggregation in both normal and AD conditions. The AD model shortened TT, APTT, and PT, indicating a procoagulant shift, whereas G-40 markedly prolonged all three parameters. G-40 also suppressed ADP-induced intracellular Ca2+ mobilization by 40-55%, with 50 uM showing the greatest effect.
Conclusions
G-40 exerts a multi-target antiplatelet and anticoagulant action in the AD-like state. Its effects are most consistently explained by attenuation of Ca2+-dependent platelet activation together with interference at common coagulation pathway steps. These findings support G-40 as a promising candidate for correcting platelet hyperreactivity and hemostatic imbalance associated with AD.
Zitieren
APA
G.K., Y., M.A., H., M.X., M., B., K. I., N.N., K., O., E. I., Z.T., K., R.N., R., & M.A., A. (2026). Reduction of Platelet Hyperactivity by Polyphenol in An Experimental Model of Alzheimer's Disease in Rats. The American Journal of Agriculture and Biomedical Engineering, 8(3), 10-16. https://doi.org/10.37547/tajabe/volume08issue03-03
Vancouver
G.K. Y, M.A. H, M.X. M, B. KI, N.N. K, O. EI, et al. Reduction of Platelet Hyperactivity by Polyphenol in An Experimental Model of Alzheimer's Disease in Rats. The American Journal of Agriculture and Biomedical Engineering. 2026;8(3):10-16. doi:10.37547/tajabe/volume08issue03-03
BibTeX
@article{GK2026,
author = {G.K., Yuldasheva and M.A., Holiqova and M.X., Muratova and B., Kоzоkоv I. and N.N., Khоshimоv and O., Erkinov I. and Z.T., Kosimova and R.N., Rakhimov and M.A., Abduganiyeva},
title = {Reduction of Platelet Hyperactivity by Polyphenol in An Experimental Model of Alzheimer's Disease in Rats},
journal = {The American Journal of Agriculture and Biomedical Engineering},
year = {2026},
volume = {8},
number = {3},
pages = {10--16},
doi = {10.37547/tajabe/volume08issue03-03}
}
EUVIMED